C. Evan Ballantyne
2014 - Synthetic Biologics
In 2014, C. Evan Ballantyne earned a total compensation of $849.1K as Former Chief Financial Officer at Synthetic Biologics, a 116% increase compared to previous year.
Compensation breakdown
Bonus | $150,000 |
---|---|
Option Awards | $355,950 |
Salary | $324,068 |
Other | $19,085 |
Total | $849,103 |
Ballantyne received $356K in option awards, accounting for 42% of the total pay in 2014.
Ballantyne also received $150K in bonus, $324.1K in salary and $19.1K in other compensation.
Rankings
In 2014, C. Evan Ballantyne's compensation ranked 8,282nd out of 13,032 executives tracked by ExecPay. In other words, Ballantyne earned more than 36.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,282 | 36th |
Manufacturing | 3,071 | 38th |
Chemicals And Allied Products | 1,042 | 38th |
Drugs | 821 | 40th |
Pharmaceutical Preparations | 635 | 39th |
Ballantyne's colleagues
We found one more compensation record of an executive who worked with C. Evan Ballantyne at Synthetic Biologics in 2014.
2014
Jeffrey Riley
Synthetic Biologics